Ana Hečimović

434 total citations
48 papers, 154 citations indexed

About

Ana Hečimović is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Oncology. According to data from OpenAlex, Ana Hečimović has authored 48 papers receiving a total of 154 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 11 papers in Epidemiology and 7 papers in Oncology. Recurrent topics in Ana Hečimović's work include Blood groups and transfusion (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Respiratory Support and Mechanisms (4 papers). Ana Hečimović is often cited by papers focused on Blood groups and transfusion (7 papers), SARS-CoV-2 and COVID-19 Research (5 papers) and Respiratory Support and Mechanisms (4 papers). Ana Hečimović collaborates with scholars based in Croatia, United States and Austria. Ana Hečimović's co-authors include Irena Jukić, Miroslav Samaržija, Tomislav Vuk, Branimir Anić, Marko Jakopović, Lorena Jemeršić, Beata Halassy, Gordana Pavliša, Tihana Kurtović and Mateja Janković Makek and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Frontiers in Immunology.

In The Last Decade

Ana Hečimović

35 papers receiving 151 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ana Hečimović Croatia 8 47 44 32 27 26 48 154
Sara García Spain 8 32 0.7× 16 0.4× 56 1.8× 14 0.5× 56 2.2× 36 229
Charlotte Colosio France 9 31 0.7× 42 1.0× 60 1.9× 11 0.4× 12 0.5× 18 254
Vítor Teixeira Portugal 6 109 2.3× 45 1.0× 42 1.3× 24 0.9× 7 0.3× 19 242
Scott Elisofon United States 10 44 0.9× 30 0.7× 64 2.0× 11 0.4× 92 3.5× 18 259
Didier Reijasse France 6 22 0.5× 26 0.6× 83 2.6× 10 0.4× 33 1.3× 7 189
Christos Koutsianas Greece 8 21 0.4× 47 1.1× 92 2.9× 7 0.3× 53 2.0× 32 206
Joanne Topliffe United Kingdom 2 42 0.9× 18 0.4× 28 0.9× 26 1.0× 6 0.2× 2 155
Prince Mohan United States 10 38 0.8× 15 0.3× 20 0.6× 9 0.3× 8 0.3× 32 254
Susan Smolen United Kingdom 3 42 0.9× 18 0.4× 29 0.9× 26 1.0× 6 0.2× 3 168
Marta Melgosa Spain 10 13 0.3× 60 1.4× 23 0.7× 13 0.5× 7 0.3× 14 256

Countries citing papers authored by Ana Hečimović

Since Specialization
Citations

This map shows the geographic impact of Ana Hečimović's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ana Hečimović with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ana Hečimović more than expected).

Fields of papers citing papers by Ana Hečimović

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ana Hečimović. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ana Hečimović. The network helps show where Ana Hečimović may publish in the future.

Co-authorship network of co-authors of Ana Hečimović

This figure shows the co-authorship network connecting the top 25 collaborators of Ana Hečimović. A scholar is included among the top collaborators of Ana Hečimović based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ana Hečimović. Ana Hečimović is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Juras, Danica Vidović, et al.. (2024). Unusual parotid gland and sublingual mucosa swelling in a 48-year-old woman. Oral Surgery Oral Medicine Oral Pathology and Oral Radiology. 138(3). 339–345. 1 indexed citations
2.
Banić, Marko, Gordana Pavliša, Ana Hečimović, et al.. (2023). Refractory systemic lupus erythematosus with chylous effusion successfully treated with sirolimus: a case report and literature review. Rheumatology International. 43(9). 1743–1749. 2 indexed citations
3.
Kurtović, Tihana, et al.. (2023). What can neutralizing antibodies tell us about the quality of immunity in COVID-19 convalescents and vaccinees?. Human Vaccines & Immunotherapeutics. 19(3). 2270310–2270310. 1 indexed citations
4.
Makek, Mateja Janković, et al.. (2023). Nintedanib treatment for bleomycin-induced lung injury - First report. Respiratory Medicine Case Reports. 46. 101921–101921. 1 indexed citations
5.
Samaržija, Miroslav, et al.. (2022). A Case of Pulmonary Co-Infection by Mycobacterium Tuberculosis and Nocardia spp. in a Lung Transplant Recipient. University of Zagreb University Computing Centre (SRCE). 41(3). 104–107.
6.
Kurtović, Tihana, et al.. (2022). Efficient and Sustainable Platform for Preparation of a High-Quality Immunoglobulin G as an Urgent Treatment Option During Emerging Virus Outbreaks. Frontiers in Immunology. 13. 889736–889736. 1 indexed citations
7.
Hečimović, Ana, Tihana Kurtović, Jelena Ivančić-Jelečki, et al.. (2022). Is Better Standardization of Therapeutic Antibody Quality in Emerging Diseases Epidemics Possible?. Frontiers in Immunology. 13. 816159–816159. 4 indexed citations
8.
Primorac, Dragan, Lenart Girandon, Ariana Barlič, et al.. (2021). Compassionate mesenchymal stem cell treatment in a severe COVID-19 patient: a case report. Croatian Medical Journal. 62(3).
9.
Primorac, Dragan, Lenart Girandon, Ariana Barlič, et al.. (2021). Compassionate mesenchymal stem cell treatment in a severe COVID-19 patient: a case report. Croatian Medical Journal. 62(3). 288–296. 10 indexed citations
10.
Brgles, Marija, et al.. (2021). Impact of complement and difference of cell-based assay and ELISA in determination of neutralization capacity against mumps and measles virus. Journal of Immunological Methods. 490. 112957–112957. 5 indexed citations
11.
Halassy, Beata, Ana Hečimović, Tihana Kurtović, et al.. (2021). COVID-19 convalescent plasma as long-term therapy in immunodeficient patients?. Transfusion Clinique et Biologique. 28(3). 264–270. 19 indexed citations
12.
Hečimović, Ana, Andrea Vukić Dugac, Mateja Janković Makek, et al.. (2019). Treatment of EGFR positive lung adenocarcinoma in a heart transplanted patient. Monaldi Archives for Chest Disease. 89(2).
13.
Bingulac-Popović, Jasna, et al.. (2019). Warm red blood cell autoantibodies and clinical diagnoses in patients with or without autoimmune hemolysis. Transfusion Clinique et Biologique. 27(1). 25–29. 3 indexed citations
14.
Hečimović, Ana, et al.. (2019). Estimation of the hepatitis E assay-dependent seroprevalence among Croatian blood donors. Transfusion Clinique et Biologique. 26(4). 229–233. 13 indexed citations
15.
Hečimović, Ana. (2019). Adaptation and Validation of the Cambridge Pulmonary Hypertension Outcome Review (CAMPHOR) for Croatia. Acta Clinica Croatica. 58(1). 3–12. 4 indexed citations
16.
Pavliša, Gordana, et al.. (2018). Neinvazivna mehanička ventilacija u kroničnoj opstruktivnoj plućnoj bolesti. Hrčak Portal of scientific journals of Croatia (University Computing Centre).
17.
Jukić, Irena, et al.. (2018). RASPODJELA GLAVNIH ALELA SUSTAVA ABO KRVNIH GRUPA U HRVATSKOJ POPULACIJI. University of Zagreb University Computing Centre (SRCE). 1 indexed citations
18.
Hečimović, Ana, et al.. (2017). Seroprevalence of hepatitis E among Croatian blood donors. 19. 2 indexed citations
19.
Jukić, Irena, et al.. (2017). DISTRIBUTION OF THE MAIN ABO BLOOD GROUP ALLELES IN CROATIAN POPULATION. 71(4). 235–240. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026